Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

LEGGE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 830
NA - Nord America 645
EU - Europa 150
AF - Africa 113
SA - Sud America 52
OC - Oceania 2
Totale 1.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 634
SG - Singapore 622
CN - Cina 147
MA - Marocco 108
DE - Germania 81
BR - Brasile 43
VN - Vietnam 16
IT - Italia 12
CZ - Repubblica Ceca 11
GB - Regno Unito 10
BD - Bangladesh 8
IN - India 8
CA - Canada 7
HK - Hong Kong 7
JP - Giappone 6
UA - Ucraina 6
FI - Finlandia 5
PL - Polonia 5
LT - Lituania 4
SE - Svezia 4
AR - Argentina 3
EC - Ecuador 3
ES - Italia 3
MX - Messico 3
NL - Olanda 3
TR - Turchia 3
ZA - Sudafrica 3
AM - Armenia 2
EG - Egitto 2
HR - Croazia 2
ID - Indonesia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
MY - Malesia 1
PK - Pakistan 1
PW - Palau 1
TJ - Tagikistan 1
TL - Timor Orientale 1
VE - Venezuela 1
Totale 1.792
Salva come PNG Salva come JPEG
Città #
Dallas 355
Singapore 243
Hefei 121
Casablanca 105
Munich 72
Ashburn 53
The Dalles 35
Los Angeles 22
Council Bluffs 17
Atlanta 14
New York 13
Boston 9
Brno 9
Brooklyn 8
Santa Clara 8
Chicago 7
Hong Kong 7
Ho Chi Minh City 6
San Francisco 6
Tokyo 6
London 5
São Paulo 5
Chennai 4
Phoenix 4
Stockholm 4
Warsaw 4
Ankara 3
Bari 3
Charlotte 3
Clifton 3
Frankfurt am Main 3
Marrakesh 3
Rome 3
Toronto 3
Turku 3
Biên Hòa 2
Cuiabá 2
Denver 2
Haiphong 2
Hanoi 2
Johannesburg 2
Kansas City 2
Milan 2
Olomouc 2
Poplar 2
San Jose 2
Seattle 2
St Petersburg 2
Tappahannock 2
Yerevan 2
Zagreb 2
Ahmedabad 1
Alexandria 1
Alfenas 1
Allen 1
Amsterdam 1
Angri 1
Aracruz 1
Arapoti 1
Baku 1
Betânia do Piauí 1
Bismarck 1
Buenos Aires 1
Cabimas 1
Cabreúva 1
Calgary 1
Campinas 1
Cape Town 1
Carmópolis de Minas 1
Cascavel 1
Catania 1
Changsha 1
Charleston 1
Cochabamba 1
Criciúma 1
Cuenca 1
Dili 1
Dubai 1
Dushanbe 1
El Progreso 1
Embu das Artes 1
Espoo 1
Fisciano 1
Guangzhou 1
Guarulhos 1
Guayaquil 1
Helena 1
Helsinki 1
Irecê 1
Islamabad 1
Ismailia 1
Jaguariaíva 1
Jiangxi 1
Joinville 1
Kabul 1
Kuala Lumpur 1
Kālīganj 1
Lençóis Paulista 1
Linares 1
Lấp Vò 1
Totale 1.250
Salva come PNG Salva come JPEG
Nome #
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 32
Biologia e genetica molecolare in ginecologia ed ostetricia 31
[Familial ovarian carcinoma] 30
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 29
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 27
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease 27
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters 26
Angiogenesis inhibitors in gynecological cancers 25
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study 25
Tumori maligni della cervice uterina 25
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 24
Advances in surgical management of cervical cancer 24
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 23
Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study 23
[Biological factors with prognostic significance in ovarian cancer]. Fattori biologici con significato prognostico nel cancro ovarico 23
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients 23
Biological characterization of ovarian cancer: prognostic and therapeutic implications 23
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 22
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III 22
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 22
Biologia e genetica molecolare in ginecologia ed ostetricia 22
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 22
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment 21
Targeted therapy for ovarian cancer 20
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 20
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept 19
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 19
Whose surgery is this? Endometriosis of the round ligament 18
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions 18
Ruolo dell'isterectomia laparoscopica nel trattamento del carcinoma della cervice uterina 17
Transplacental carcinogenesis: state of the art 17
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer 17
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations 17
Progestin-realising intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 17
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters 17
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. 17
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis 17
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 16
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery 16
Intensity-modulated extended field chemoradiation plus simultaneous integrated boost in the preoperative treatment of locally advanced cervical cancer: a dose-escalation study 16
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 16
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures 16
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 16
Targeted therapies in gynecological cancers 16
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects 16
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 16
Tumori maligni della cervice uterina 15
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 15
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing Preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 15
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 15
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer 15
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients 15
Simultaneous integrated boost volumetric modulated Arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase I-II trial 15
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report 15
Cyclooxygenase-2 expression in borderline ovarian tumors 15
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 15
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 15
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 14
Clinical role of Cyclooxygenase-2 (COX-2) expression in tumor and stromal component of cervical cancer 14
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: Feasibility and clinical results 14
Endometriosis and Cancer 14
Tumori dell'ovaio 14
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 14
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 14
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 14
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients 14
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 14
Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases 14
Which role for pre-treatment laparoscopic staging? 14
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 14
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? 14
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome 13
Nerve-sparing laparoscopic colposacropexy using a percutaneous surgical system: a case report 13
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer 13
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 13
New drugs in ovarian cancer 13
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 13
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 13
Laparoscopic en bloc right diaphragmatic peritonectomy for diaphragmatic endometriosis according to the Sugarbaker technique 13
Fattori prognostici nel carcinoma ovarico epiteliale 13
Prospettive future per i tumori della cervice uterina 13
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer 13
Fertility-Sparing Surgery in Ovarian Cancer Extended beyond the Ovaries: A Case Report and Review of the Literature 13
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective, Phase II Study 13
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 13
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 13
Il carcinoma ovarico familiare 13
The peritoneal cavity: tumor metastasis and growth 13
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 13
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients 12
COX-2 inhibition in gynaecological cancers 12
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 12
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 12
Gene therapy in gyncological cancer 12
New insights in biological characterization of ovarian cancer 12
Corticotropin-releasing hormone receptor-1 in human endometrial cancer 12
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 12
Participation of patients with gynecological cancer in phase I clinical trials: Two years experience in a major cancer center 12
Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy 12
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 11
Totale 1.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024203 0 0 0 121 9 2 0 1 24 30 4 12
2024/2025659 19 48 40 24 74 2 1 24 193 13 110 111
2025/20261.051 95 371 221 261 55 48 0 0 0 0 0 0
Totale 1.913